Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Genetics in psychiatry.

Umesh S, Nizamie SH.

Indian J Hum Genet. 2014 Apr;20(2):120-8. doi: 10.4103/0971-6866.142845. Review.

PMID:
25400339
[PubMed]
Free PMC Article
2.

GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.

Dobson-Stone C, Polly P, Korgaonkar MS, Williams LM, Gordon E, Schofield PR, Mather K, Armstrong NJ, Wen W, Sachdev PS, Kwok JB.

PLoS One. 2013 Aug 12;8(8):e71750. doi: 10.1371/journal.pone.0071750. eCollection 2013.

PMID:
23951236
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative.

Meda SA, Koran ME, Pryweller JR, Vega JN, Thornton-Wells TA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2013 May;34(5):1518.e9-18. doi: 10.1016/j.neurobiolaging.2012.09.020. Epub 2012 Oct 27.

PMID:
23107432
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?

Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Williams S.

Int J Alzheimers Dis. 2012;2012:276803. doi: 10.1155/2012/276803. Epub 2012 Jun 14.

PMID:
22779025
[PubMed]
Free PMC Article
5.

Tau Phosphorylation by GSK3 in Different Conditions.

Avila J, León-Espinosa G, García E, García-Escudero V, Hernández F, Defelipe J.

Int J Alzheimers Dis. 2012;2012:578373. doi: 10.1155/2012/578373. Epub 2012 May 17.

PMID:
22675648
[PubMed]
Free PMC Article
6.

Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.

Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J.

Int J Alzheimers Dis. 2012;2012:630182. doi: 10.1155/2012/630182. Epub 2012 Mar 8.

PMID:
22482074
[PubMed]
Free PMC Article
7.

Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Cacabelos R, Martínez R, Fernández-Novoa L, Carril JC, Lombardi V, Carrera I, Corzo L, Tellado I, Leszek J, McKay A, Takeda M.

Int J Alzheimers Dis. 2012;2012:518901. doi: 10.1155/2012/518901. Epub 2012 Mar 14.

PMID:
22482072
[PubMed]
Free PMC Article
8.

Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib.

Domínguez JM, Fuertes A, Orozco L, del Monte-Millán M, Delgado E, Medina M.

J Biol Chem. 2012 Jan 6;287(2):893-904. doi: 10.1074/jbc.M111.306472. Epub 2011 Nov 18.

PMID:
22102280
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.

Wexler EM, Rosen E, Lu D, Osborn GE, Martin E, Raybould H, Geschwind DH.

Sci Signal. 2011 Oct 4;4(193):ra65. doi: 10.1126/scisignal.2002282.

PMID:
21971039
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.

Ali YO, Ruan K, Zhai RG.

Hum Mol Genet. 2012 Jan 15;21(2):237-50. doi: 10.1093/hmg/ddr449. Epub 2011 Sep 30.

PMID:
21965302
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Khandelwal PJ, Dumanis SB, Herman AM, Rebeck GW, Moussa CE.

Mol Cell Neurosci. 2012 Jan;49(1):44-53. doi: 10.1016/j.mcn.2011.09.002. Epub 2011 Sep 14.

PMID:
21945393
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration.

Salcedo-Tello P, Ortiz-Matamoros A, Arias C.

Int J Alzheimers Dis. 2011;2011:189728. doi: 10.4061/2011/189728. Epub 2011 May 4.

PMID:
21660241
[PubMed]
Free PMC Article
13.

Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Lanctôt KL, Rajaram RD, Herrmann N.

Ther Adv Neurol Disord. 2009 May;2(3):163-80. doi: 10.1177/1756285609102724.

PMID:
21179526
[PubMed]
Free PMC Article
14.

Biana: a software framework for compiling biological interactions and analyzing networks.

Garcia-Garcia J, Guney E, Aragues R, Planas-Iglesias J, Oliva B.

BMC Bioinformatics. 2010 Jan 27;11:56. doi: 10.1186/1471-2105-11-56.

PMID:
20105306
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Drug development for Alzheimer's disease: where are we now and where are we headed?

Sabbagh MN.

Am J Geriatr Pharmacother. 2009 Jun;7(3):167-85. doi: 10.1016/j.amjopharm.2009.06.003. Review.

PMID:
19616185
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

Small SA, Duff K.

Neuron. 2008 Nov 26;60(4):534-42. doi: 10.1016/j.neuron.2008.11.007. Review.

PMID:
19038212
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk